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Clinical PerspectiveWhat Is New?Using arterial spin labeling (a magnetic resonance technique that does not require contrast) to measure cerebral blood flow in patients with acute and subacute intracerebral hemorrhage, perihematomal cerebral blood flow was not associated with systolic blood pressure changes at any time point.What Are the Clinical Implications?Our results add to the body of literature showing that subacute ischemic lesions occurring in patients with an intracerebral hemorrhage are not related to blood pressure, which is relevant to antihypertensive therapy in this patient population.

 {#jah34054-sec-0009}

Management of acute hypertension in patients with an intracerebral hemorrhage (ICH) remains an area of clinical equipoise.[1](#jah34054-bib-0001){ref-type="ref"} The most recent large randomized clinical trial demonstrated a trend to worse outcomes when systolic blood pressure (SBP) was aggressively lowered (\<140 mm Hg).[1](#jah34054-bib-0001){ref-type="ref"}, [2](#jah34054-bib-0002){ref-type="ref"}, [3](#jah34054-bib-0003){ref-type="ref"} Several magnetic resonance imaging (MRI) studies have demonstrated subacute ischemic lesions in patients with ICH. One of the hypothesized causes for both these ischemic lesions and worse outcomes after aggressive SBP lowering is impairment of cerebral perfusion.

Multiple studies of cerebral blood flow (CBF) in patients with ICH have demonstrated that there is a modest degree of regional hypoperfusion.[4](#jah34054-bib-0004){ref-type="ref"}, [5](#jah34054-bib-0005){ref-type="ref"}, [6](#jah34054-bib-0006){ref-type="ref"}, [7](#jah34054-bib-0007){ref-type="ref"} In addition, one randomized study demonstrated that the magnitude of hypoperfusion was unaffected by SBP reduction.[8](#jah34054-bib-0008){ref-type="ref"}, [9](#jah34054-bib-0009){ref-type="ref"} All of these studies of CBF have been limited to single assessments of perfusion at only one time point relatively early after symptom onset. Serial CBF measurements were not obtained because of the safety concerns associated with the contrast agents used to obtain perfusion measurements in these studies.

Arterial spin labeling (ASL) is an MRI technique that can be used to measure relative CBF (rCBF) without the need for a gadolinium‐based contrast agent.[10](#jah34054-bib-0010){ref-type="ref"}, [11](#jah34054-bib-0011){ref-type="ref"}, [12](#jah34054-bib-0012){ref-type="ref"} We used ASL to measure CBF in patients with acute and subacute ICH. We tested the hypothesis that ASL measures of CBF are linearly related to SBP.

Materials and Methods {#jah34054-sec-0010}
=====================

Patients {#jah34054-sec-0011}
--------

All patients were prospectively recruited into the study, as part of the ongoing ICH ADAPT II (Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II; ***Clinical Trial Registration***---URL: <http://www.clinicaltrials.gov>. Unique identifier: NCT00963976). The data will be added to The Virtual International Stroke Trials Archive (VISTA) ICH database once the ICH ADAPT II is completed. The data that support the findings of this study are available from the corresponding author on reasonable request. Patient inclusion/exclusion criteria for this trial have been previously published.[13](#jah34054-bib-0013){ref-type="ref"} Briefly, this is a randomized evaluation of SBP reduction targets on the frequency of diffusion‐weighted imaging (DWI) lesions in patients with ICH. Patients aged ≥18 years, presenting with computed tomography--confirmed acute primary ICH within 6 hours of symptom onset and baseline SBP \>180 mm Hg, were eligible. Exclusion criteria included evidence of secondary ICH, planned surgical resection, and contraindications to antihypertensive therapy or MRI. Patients were randomly assigned to SBP \<140 or \<180 mm Hg. BP was monitored using labetalol, enalapril, and/or hydralazine. Informed consent was obtained in all cases. The trial was approved by the human research ethics board at the University of Alberta (Edmonton, Alberta, Canada). Analysis of the ASL data, obtained as part of this trial, was completed by investigators (A.K. and K.B.) who remain blinded to the randomized SBP treatment target.

Clinical Assessment {#jah34054-sec-0012}
-------------------

Baseline demographic information and medical history were collected as part of the trial case report form. The National Institutes of Health Stroke Scale score was obtained at time of admission. SBP was recorded during the first 24 hours.

Imaging Acquisition Protocol {#jah34054-sec-0013}
----------------------------

Noncontrast computed tomographic scans (Siemens Somatom, Erlangen, Germany) were acquired within 6 and 24 hours after symptom onset. The computed tomography consisted of 5‐mm slices, with no gap (120 peak kV, 300 mA per slice) through the entire brain (18--20 slices with a 512×512 matrix). MRI was performed on a 3.0‐T instrument (Siemens Magnetom Prisma, Erlangen, Germany) with a 64‐element phased array at 48 hours, day 7, and/or day 30 from symptom onset. The MRI protocol included pulsed ASL (voxel size, 2 mm, isotropic: repetition time, 4600 ms; echo time, 18.8 ms; voxel size, 3 mm: repetition time, 3500 ms; echo time, 16.2 ms), susceptibility‐weighted imaging (voxel size, 0.7×0.7×2.0 mm^3^: repetition time, 28.0 ms; echo time, 20.00 ms), and DWI (voxel size, 0.7×0.7×1.5 mm^3^: repetition time, 4890 ms; echo time, 51.0 ms; b values of 1000 s/mm^2^; 20 gradient directions). The acquisition used 3‐dimensional Turbo gradient‐spin‐echo (TGSE) Flow‐sensitive Alternating Inversion Recovery Quantitative Imaging of Perfusion Using a Single Subtraction II (FAIR QUIPSS) tagging with bolus duration of 700 ms and inversion time of 1990 ms.

Image Analysis {#jah34054-sec-0014}
--------------

Planimetric assessment of acute and 24‐hour computed tomographic hematoma volumes was performed using Quantomo software, a semiautomated, threshold‐based, seed‐growing algorithm.[14](#jah34054-bib-0014){ref-type="ref"} Perihematomal edema and susceptibility‐weighted imaging hematoma volumes were calculated with the Analyze 11.0 software package (Biomedical Imaging Resource, Mayo Clinic).

ASL data were used to generate maps of CBF with MIStar (Apollo Medical Imaging Technology, Melbourne, Victoria, Australia; Figure [1](#jah34054-fig-0001){ref-type="fig"}).[11](#jah34054-bib-0011){ref-type="ref"}, [15](#jah34054-bib-0015){ref-type="ref"} The maps of CBF were coregistered to susceptibility‐weighted imaging and DWI images for region of interest (ROI) analysis. ROIs included the perihematomal region (1 cm surrounding the hematoma), ipsilateral and contralateral hemispheres, internal border zones, and external border zones. rCBF was calculated as the ratio of the mean values within each ROI/contralateral homologous regions at each time point.[8](#jah34054-bib-0008){ref-type="ref"}, [9](#jah34054-bib-0009){ref-type="ref"} Perilesional ROIs consisted of a 1‐cm ring surrounding DWI hyperintensities (ischemic lesions).

![**A**, The hematoma was delineated using susceptibility‐weighted images (SWIs; **left**), which were then coregistered with arterial spin labeling (ASL) scans (**right**). Regions of interest included perihematoma, hemisphere, internal and external border zones (IBZs and EBZs, respectively), and the contralateral homologous regions. **B**, Ischemic lesions were identified with diffusion‐weighted imaging (DWI) and coregistered with ASL scans. The area surrounding the ischemic lesion was compared with a homologous contralesional area.](JAH3-8-e010904-g001){#jah34054-fig-0001}

Statistical Analysis {#jah34054-sec-0015}
--------------------

Statistical analysis was performed using SPSS Statistics 21.0 2008 (IBM, Armonk, NY). Weighted average SBPs were calculated as the area under the curve describing pressures \>24 hours, as previously described.[8](#jah34054-bib-0008){ref-type="ref"}, [16](#jah34054-bib-0016){ref-type="ref"} Low SBP load was defined as the percentage of time spent at \<140 mm Hg and high SBP load was defined as the percentage of time spent at \>180 mm Hg within the first 24 hours from symptom onset.[8](#jah34054-bib-0008){ref-type="ref"}, [17](#jah34054-bib-0017){ref-type="ref"} There were insufficient SBP measurements available to calculate loads over time in one patient who had scans at the 48‐hour, day 7, and day 30 time points. Absolute ASL signal intensity values at each time point were analyzed with a 1‐way ANOVA to determine differences in perfusion between hemispheres. rCBF values at each time point were compared using the related‐samples Friedman\'s ANOVA on ranks. Univariate linear regression was used to assess the relationships between SBP at the time of the scan, SBP change from baseline, SBP weighted average, percentage of time spent with SBP \<140 and SBP \>180 mm Hg within the first 24 hours, hematoma size, and rCBF at each time point. All nonnormally distributed variables were log transformed before regression.

Results {#jah34054-sec-0016}
=======

Patient Characteristics {#jah34054-sec-0017}
-----------------------

Twenty patients underwent imaging with ASL at 48 hours (N=12) and/or day 7 (N=6) and/or day 30 (N=11). Three patients had scans at all time points. Seven patients had scans at 48 hours only, 2 had scans at day 7 only, and 5 had scans at day 30 only. Two patients had a scan at 48 hours and day 30, and one patient had scans at day 7 and day 30. At 48 hours, 2 patients did not receive a scan, and 6 were scanned without the ASL protocol. At day 7, 2 patients died, 2 patients withdrew from the study, 9 patients did not receive a scan, and 1 patient was acquired without the ASL protocol. At day 30, 5 patients did not receive a scan. The ASL protocol was not used in every MRI scan as the acquisition requires patient cooperation for several minutes, which was not always possible in the patients with ICH. When ASL data were not obtained, SBP data and other parameters were excluded from summative data and regression analyses. Mean±SD times from symptom onset to scan at each of the 3 time points (48 hours, day 7, and day 30) were 57.1±24.1 hours, 9.2±2.3 days, and 39.3±12.5 days, respectively. Baseline patient characteristics are described in Table [1](#jah34054-tbl-0001){ref-type="table"}.

###### 

Baseline Patient Characteristics

  Characteristics                                                 Values
  --------------------------------------------------------------- ------------------
  Age, mean±SD, y                                                 68.50±12.72
  Sex, % men                                                      65
  NIHSS score, median (quartile 1--quartile 3)                    12 (9--16)
  Acute hematoma volume, median (quartile 1--quartile 3), mL      13.1 (6.3--19.3)
  Hematoma volume at 24 h, median (quartile 1--quartile 3), mL    15.6 (7.3--35.5)
  Edema at 24 h (5--23 HU), median (quartile 1--quartile 3), mL   2.5 (1.2--9.3)
  SBP, mean±SD, mm Hg                                             185.4±25.5
  Hematoma location                                               
  Cortical                                                        4
  Subcortical                                                     15
  Cerebellum                                                      1

HU indicates Hounsfield unit; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure.
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Measurements of CBF {#jah34054-sec-0018}
-------------------

Measurements of CBL are described in Table [2](#jah34054-tbl-0002){ref-type="table"}. There were no differences in ASL perfusion measurements at any time points in any of the ROIs (*P*≥0.422; Figure [2](#jah34054-fig-0002){ref-type="fig"}A through [2](#jah34054-fig-0002){ref-type="fig"}C). There were no differences in rCBF at any time points in any of the other ROIs (*P*≥0.097; Figure [3](#jah34054-fig-0003){ref-type="fig"}). We also separately compared the rCBF of those patients who had ≥1 follow‐up scans and did not find a difference between baseline and follow‐up (*P*≥0.198; Table [S1](#jah34054-sup-0001){ref-type="supplementary-material"}). Four patients developed DWI ischemic lesions at 27 hours, 6 days, 35 days, and 36 days (Table [2](#jah34054-tbl-0002){ref-type="table"} and Figure [S1](#jah34054-sup-0001){ref-type="supplementary-material"}). There were no differences in ASL perfusion measures within the areas of diffusion restriction (Figure [2](#jah34054-fig-0002){ref-type="fig"}D).

###### 

Absolute ASL Intensity Difference Values and rCBF Measurements

  Region of Interest                   Ipsilateral Absolute Value   Contralateral Absolute Value   rCBF
  ------------------------------------ ---------------------------- ------------------------------ ---------
  48‐Hour perihematoma                 76.2±34.4                    88.9±41.6                      0.9±0.2
  48‐Hour hemisphere                   92.1±25.8                    97.7±25.4                      1.0±0.1
  48‐Hour internal border zone         37.1±23.4                    42.2±29.7                      1.0±0.2
  48‐Hour external border zone         54.9±27.3                    62.0±29.4                      0.9±0.2
  Day 7 perihematoma                   52.9±22.2                    62.7±28.0                      0.9±0.3
  Day 7 hemisphere                     65.9±31.1                    71.4±32.0                      0.9±0.1
  Day 7 internal border zone           40.4±37.5                    39.7±31.5                      1.0±0.2
  Day 7 external border zone           42.7±34.4                    44.8±28.6                      1.0±0.3
  Day 30 perihematoma                  65.1±29.7                    73.5±30.9                      0.9±0.2
  Day 30 hemisphere                    60.85±26.09                  64.32±30.39                    1.0±0.2
  Day 30 internal border zone          32.8±26.8                    34.9±25.2                      0.9±0.2
  Day 30 external border zone          40.3±21.4                    45.2±26.4                      1.0±0.4
  DWI lesions (all time points; N=4)   70.0±49.2                    77.3±86.8                      1.0±0.7

Data are given as mean±SD. ASL indicates arterial spin labeling; DWI, diffusion‐weighted imaging; rCBF, relative cerebral blood flow.
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![Absolute arterial spin labeling (ASL) signal intensity values in the perihematomal, hemispheric, and internal and external border zone areas in the ipsilateral and contralateral sides to the hematoma at 48 hours (**A**), on day 7 (**B**), and on day 30 (**C**) were not different. **D**, The ipsilateral and contralateral absolute ASL signal intensity values were combined for all the time points for the participants with diffusion‐weighted imaging lesions, which did not differ either.](JAH3-8-e010904-g002){#jah34054-fig-0002}

![Perihematomal (**A**), ipsilateral hemispheric (**B**), and internal (**C**) and external (**D**) border zone relative cerebral blood flow (rCBF) values in individual patients. ANOVA results indicated no differences over time in any of the regions examined.](JAH3-8-e010904-g003){#jah34054-fig-0003}

Temporal BP Profile {#jah34054-sec-0019}
-------------------

The mean±SD SBP was 145.0±19.5, 133.3±19.5, and 139.1±12.3 mm Hg at 48 hours, day 7, and day 30, respectively (Figure [4](#jah34054-fig-0004){ref-type="fig"}A). The SBP decreased by a mean±SD of 46.6±20.7, 57.6±32.4, and 53.0±30.1 mm Hg at 48 hours, day 7, and day 30, respectively. The mean±SD weighted average SBP was 146.2±17.3 mm Hg (N=17). The median (quartile 1--quartile 3) SBP load of \<140 mm Hg at 48 hours was 18.7% (4.2%--35.4%; N=17). The median (quartile 1--quartile 3) SBP load of \>180 mm Hg at 48 hours was 0% (0%--4.2%; N=17).

![**A**, Temporal profile of mean (95% CI) of systolic blood pressure (SBP) profile up to 48 hours, as well as at day 7 and day 30. SBP at 48 hours was not associated with relative cerebral blood flow (rCBF) in the perihematoma (**B**), hemisphere (**C**), or border zones (**D**).](JAH3-8-e010904-g004){#jah34054-fig-0004}

Relationship Between SBP and CBF {#jah34054-sec-0020}
--------------------------------

SBP was not associated with rCBF in any region at any time point (*P*≥0.111; Figure [4](#jah34054-fig-0004){ref-type="fig"}B through [4](#jah34054-fig-0004){ref-type="fig"}D; Table [3](#jah34054-tbl-0003){ref-type="table"}, Tables [S2](#jah34054-sup-0001){ref-type="supplementary-material"} and [S3](#jah34054-sup-0001){ref-type="supplementary-material"}). SBP, including at the time of baseline, was also not associated with perilesional rCBF in those patients with DWI lesions (*P*≥0.105).

###### 

Univariate Relationships Between rCBF and BP Control at 48 Hours in the Perihematomal Region, Ipsilateral Hemisphere, and Internal and External Border Zones

  rCBF at 48 h               No. of Patients[a](#jah34054-note-0005){ref-type="fn"}   β Value   Unstandardized B Value   95% CI            *P* Value
  -------------------------- -------------------------------------------------------- --------- ------------------------ ----------------- -----------
  Perihematoma                                                                                                                             
  SBP change from baseline   11                                                       −0.005    −0.00004                 −0.013 to 0.013   0.993
  Weighted average SBP       10                                                       −0.621    −0.008                   −0.092 to 0.076   0.783
  SBP load \<140 mm Hg       10                                                       −1.450    −1.137                   −5.719 to 3.445   0.487
  SBP load \>180 mm Hg       10                                                       −0.354    −0.382                   −3.186 to 2.422   0.694
  Hemisphere                                                                                                                               
  SBP change from baseline   11                                                       −0.193    0.000                    −0.003 to 0.002   0.622
  Weighted average SBP       10                                                       2.114     0.009                    −0.010 to 0.027   0.233
  SBP load \<140 mm Hg       10                                                       2.076     0.511                    −0.480 to 1.502   0.199
  SBP load \>180 mm Hg       10                                                       −0.657    −0.222                   −0.829 to 0.384   0.328
  Internal border zone                                                                                                                     
  SBP change from baseline   11                                                       −0.209    −0.002                   −0.018 to 0.014   0.725
  Weighted average SBP       10                                                       0.882     0.013                    −0.090 to 0.116   0.712
  SBP load \<140 mm Hg       10                                                       −0.240    −0.218                   −5.809 to 5.373   0.909
  SBP load \>180 mm Hg       10                                                       −0.514    −0.643                   −4.064 to 2.778   0.592
  External border zone                                                                                                                     
  SBP change from baseline   11                                                       −0.015    −0.00008                 −0.008 to 0.008   0.978
  Weighted average SBP       10                                                       1.490     0.013                    −0.042 to 0.067   0.515
  SBP load \<140 mm Hg       10                                                       0.438     0.226                    −2.739 to 3.192   0.824
  SBP load \>180 mm Hg       10                                                       −0.817    −0.580                   −2.394 to 1.234   0.384

BP indicates blood pressure; rCBF, relative cerebral blood flow; SBP, systolic BP.

There were insufficient data points to calculate weighted average SBP in one patient.
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Hematoma volume was associated with decreased day 7 hemispheric rCBF (β=−0.892, *P*=0.042), but no other regions of interest (*P*≥0.074), including perilesional rCBF in those patients with DWI lesions (β=−0.689, *P*=0.311).

Discussion {#jah34054-sec-0021}
==========

We have shown that ASL measurements of rCBF up to 30 days after ICH are feasible. Consistent with other studies of perfusion in ICH, ASL measurements failed to demonstrate lower rCBF in patients with lower BP. In a limited number of patients with ischemic lesions, we found evidence of perilesional hypoperfusion in the patients with scans at 48 hours and on day 7 and slight hyperperfusion in the 2 remaining patients with day 30 scans, but CBF did not appear related to SBP.

Evidence from small and large clinical trials suggests that although aggressive antihypertensive therapy to 140 to 150 mm Hg has failed to improve patient outcome, it is relatively safe.[1](#jah34054-bib-0001){ref-type="ref"}, [2](#jah34054-bib-0002){ref-type="ref"}, [3](#jah34054-bib-0003){ref-type="ref"} In a positron emission tomography study, reduction of mean arterial pressure in 14 patients with ICH by 15% between 6 and 22 hours from symptom onset did not lead to decreased perihematomal or hemispheric CBF.[18](#jah34054-bib-0018){ref-type="ref"} In the ICH ADAPT I, in which patients were randomized to a conservative (\<180 mm Hg) or aggressive (150 mm Hg) SBP target, perfusion was not affected by decreased SBP.[9](#jah34054-bib-0009){ref-type="ref"}

In this study, we also found that SBP changes were unrelated to rCBF in different regions of interest and across all time points, up to 30 days after ICH. Our results are consistent with previous research suggesting that there are no adverse effects on brain autoregulation caused by decreased SBP.

Remote ischemic lesions are found within a week of ICH onset in 14% to 41% of patients, and they have been associated with higher rates of morbidity and mortality.[19](#jah34054-bib-0019){ref-type="ref"}, [20](#jah34054-bib-0020){ref-type="ref"}, [21](#jah34054-bib-0021){ref-type="ref"}, [22](#jah34054-bib-0022){ref-type="ref"}, [23](#jah34054-bib-0023){ref-type="ref"}, [24](#jah34054-bib-0024){ref-type="ref"}, [25](#jah34054-bib-0025){ref-type="ref"} Previously reported associations include hematoma volume, leukoaraiosis, amyloid angiopathy, microbleeds, and history of antihypertensive and antiplatelet therapy.[19](#jah34054-bib-0019){ref-type="ref"}, [20](#jah34054-bib-0020){ref-type="ref"}, [21](#jah34054-bib-0021){ref-type="ref"}, [22](#jah34054-bib-0022){ref-type="ref"}, [23](#jah34054-bib-0023){ref-type="ref"}, [24](#jah34054-bib-0024){ref-type="ref"} Retrospective studies are contradictory with respect to the association between SBP lowering and DWI lesions.[20](#jah34054-bib-0020){ref-type="ref"}, [25](#jah34054-bib-0025){ref-type="ref"}, [26](#jah34054-bib-0026){ref-type="ref"} We found no consistent perilesional hypoperfusion in the 4 patients with ICH and remote DWI hyperintensities. Although larger hematoma volumes were associated with lower hemispheric perfusion at day 7, ischemic lesions were not. Most important, we did not find a relationship between perilesional rCBF and SBP. The ICH ADAPT II, which is currently ongoing, is a prospective randomized and blinded trial that will shed light on the impact of aggressive SBP lowering on DWI lesion frequency after ICH.[13](#jah34054-bib-0013){ref-type="ref"}

Limitations of this study include the relatively small number of patients and loss to follow‐up caused by morbidity and mortality, which may have led to selection bias. ASL sequences are several minutes long and require a cooperative and stable patient, which is often not the case shortly after ICH. The relative ASL measurements may have masked more global decreases in cerebral perfusion. Nonetheless, our findings are consistent with the bulk of evidence to date suggesting that lower SBP is not associated with hypoperfusion in patients with ICH.

Summary/Conclusions {#jah34054-sec-0022}
===================

This is the first study that measured CBF using ASL, a noninvasive MRI technique, to measure perfusion in patients with ICH. Although we found no evidence that lower pressures were associated with subacute or late changes in cerebral perfusion, a randomized trial is required to definitively determine if aggressive BP targets affect CBF.
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###### 

**Table S1.** Relative Cerebral Blood Flow (rCBF) of Patients With a 48 Hours and Follow Up Scan

**Table S2.** Linear Regression Between Day 7 rCBF and Systolic Blood Pressure (SBP), SBP Difference From Baseline, Weighted Average SBP, and SBP Loads

**Table S3.** Linear Regression Between Day 30 rCBF and Systolic Blood Pressure (SBP), Weighted Average SBP, SBP Difference From Baseline and SBP Loads

**Figure S1.** Relative cerebral blood flow (rCBF) in the perilesional region of the four patients (one at 48 hours, one at Day 7, and two at Day 30) with DWI lesions remote to the hematoma.

###### 

Click here for additional data file.
